The original paper, ‘CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction,’ can be found here: ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

CryoTherapeutics is dedicated to advancing the understanding of high-risk ("vulnerable") plaques and exploring innovative approaches to stabilize them. Although often angiographically non-obstructive, ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

Symptomatic people with evidence of coronary artery disease on imaging significantly benefited from statin use while those without did not.

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in blood and tissues, with multisystem involvement. Cardiac manifestations are ...

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial Receive the the latest news, research, and presentations from major meetings ...

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...